Nephros, Inc.

$3.07 ▼ -2.21%

2026-04-21 08:22:01

Explore Nephros, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap

$32.68 M

Current Price

$3.07

52W High / Low

$6.42 / $1.64

Stock P/E

27.37

Book Value

$0.96

Dividend Yield

—

ROCE

10.54%

ROE

12.71%

Face Value

—

EPS

$0.11

Exp Qtr EPS

—

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

36

Beta

1.56

Debt / Equity

10.42

Current Ratio

4.06

Quick Ratio

2.89

Forward P/E

22.77

Price / Sales

1.68

Enterprise Value

$27.17 M

EV / EBITDA

21.14

EV / Revenue

1.45

Rating

None

Target Price

$7

EPS Forecast (FY)

—

ABOUT

In essence, nephros, Inc., a commercial-stage This organization, is focused on developing and markets and sells water filtration solutions for medical and commercial applications in the United States. In essence, it delivers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. In essence, this organization also handles the manufacturing of and markets and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. In essence, it markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. In essence, this organization was incorporated in 1997 and is headquartered in South Orange, New Jersey. ROE at 12.71% based on the latest available annual data. ROCE at 10.54% using operating income and capital employed. Debt to equity stands at 0.10x. Operating margin is 0.38% on trailing numbers. Trailing twelve month sales are available in the dataset.

Pros

Balance sheet leverage appears manageable.
Short-term liquidity looks comfortable.

Cons

Operating margin is thin.

Sift Stocks

S.No.	Name	Price	P.E.	Market Cap	Div Yld %	ROCE	ROE	52Week High/ Low	Book Value
1.	Align Technology, Inc.	$194.19	34.46	$14 B	—	13.57%	10.39%	$208.31 / $122	$56.74
2.	Bausch + Lomb Corporation	$16.76	—	$5.94 B	—	1.55%	-5.39%	$18.91 / $10.45	$18.2
3.	ICU Medical, Inc.	$130.58	4,461.76	$3.27 B	—	3.08%	0.04%	$160.29 / $107	$86.03
4.	AptarGroup, Inc.	$125.33	21.29	$8.05 B	1.47%	12.5%	15.1%	$164.28 / $103.23	$41.56
5.	Precision Optics Corporation, Inc.	$4.44	—	$47.43 M	—	-40.7%	-73.56%	$6.04 / $3.55	$1.21
6.	Stevanato Group S.p.A.	$15.86	26.32	$4.33 B	0.39%	9.9%	9.67%	$28 / $12.89	$6.28
7.	Milestone Scientific Inc.	$0.29	—	$23.33 M	—	-155%	-1.32%	$1.11 / $0.22	$0.04

Quarterly Results

Figures shown in M / B

	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024
Sales	4.73 M	4.76 M	4.42 M	4.88 M	3.87 M	—
Operating Profit	0.02 M	0.31 M	0.25 M	0.57 M	0.32 M	—
Net Profit	0.06 M	0.34 M	0.24 M	0.56 M	0.35 M	—
EPS in Rs	0.01	0.03	0.02	0.05	0.03	0.02

Profit & Loss

Figures shown in M / B

	2025	2024	2023	2022
Sales	18.79 M	14.16 M	14.24 M	9.97 M
Operating Profit	1.15 M	0.01 M	-1.59 M	-4.33 M
Net Profit	1.19 M	0.07 M	-1.57 M	-7.38 M
EPS in Rs	0.11	0.01	-0.15	-0.69

Balance Sheet

Figures shown in M / B

	2025	2024	2023	2022
Total Assets	13.64 M	11.21 M	11.86 M	11 M
Total Liabilities	3.44 M	2.62 M	3.5 M	2.12 M
Equity	10.2 M	8.59 M	8.36 M	5.59 M
Current Assets	11.22 M	8.3 M	8.4 M	8.26 M
Current Liabilities	2.77 M	1.56 M	2.11 M	1.41 M

Cash Flow

Last available yearly cash flow history

	2025	2024	2023	2022
Operating CF	1.65 M	-0.49 M	0.83 M	-3.23 M
Investing CF	0 M	-0.05 M	-0.07 M	-0.14 M
Financing CF	-0.01 M	-0.01 M	-0.08 M	0.03 M
Free CF	1.65 M	-0.55 M	0.75 M	-3.37 M
Capex	—	-0.06 M	-0.07 M	-0.14 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

	2024	2023	2022	2021
Revenue Growth %	-0.53%	42.74%	—	—
Earnings Growth %	104.7%	78.66%	—	—
Profit Margin %	0.52%	-11.06%	-74.01%	—
Operating Margin %	0.04%	-11.19%	-43.46%	—
Gross Margin %	61.59%	59.03%	47.43%	—
EBITDA Margin %	1.6%	-9.54%	-39.16%	—

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name	Type	Shares	Value	% Out	Report Date
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund	Mutual Fund	0.03 M	$0.09 M	0%	2026-02-28
Fidelity Concord Street Trust-Fidelity Total Market Index Fund	Mutual Fund	0.01 M	$0.03 M	0%	2026-02-28
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund	Mutual Fund	0.01 M	$0.03 M	0%	2026-02-28
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund	Mutual Fund	0 M	$0.01 M	0%	2026-02-28
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Sustainability Core 1 PORT.	Mutual Fund	0 M	$0.01 M	0%	2026-01-31
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Core Equity 2 Portfolio	Mutual Fund	0 M	$0.01 M	0%	2026-01-31
Dimensional ETF Trust-Dimensional US Core Equity 1 ETF	Mutual Fund	0 M	$0.01 M	0%	2026-01-31
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Core Equity 1 Portfolio	Mutual Fund	0 M	$0.01 M	0%	2026-01-31
Wexford Capital LP	Institutional	3.62 M	$10.38 M	0.47%	2025-12-31
Topline Capital Management, LLC	Institutional	0.61 M	$1.76 M	0.08%	2025-12-31
Vanguard Group Inc	Institutional	0.23 M	$0.67 M	0.03%	2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	Mutual Fund	0.13 M	$0.37 M	0.02%	2025-12-31
Bard Associates Inc.	Institutional	0.12 M	$0.35 M	0.02%	2025-12-31
Renaissance Technologies, LLC	Institutional	0.1 M	$0.3 M	0.01%	2025-12-31
Geode Capital Management, LLC	Institutional	0.07 M	$0.21 M	0.01%	2025-12-31